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Reactive oxygen speciesodiﬁed phospholipids on the association with model biomembranes of four
antimicrobial peptides (AMPs), temporin B and L, indolicidin, and LL-37(F27W) were studied by Langmuir
balance and ﬂuorescence spectroscopy. In keeping with previous reports the negatively charged
phospholipid phosphatidylglycerol (PG) enhanced the intercalation of all four peptides into lipid monolayers
and liposomal bilayers under low ionic strength conditions. Interestingly, similar effect was observed for 1-
palmitoyl-2-(9′-oxo-nonanoyl)-sn-glycero-3-phosphocholine (PoxnoPC), a zwitterionic oxidized phospholi-
pid bearing an aldehyde function at the end of its truncated sn-2 acyl chain. Instead, the structurally similar
1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine (PazePC) containing a carboxylic moiety was less
efﬁcient in promoting the membrane association of these peptides. Physiological saline reduced the binding
of the above peptides to membranes containing PG, whereas interactions with PoxnoPC were found to be
insensitive to ionic strength. Notably, membrane intercalation of temporin L, the most surface active of the
above peptides could be into PoxnoPC containing monolayers was strongly attenuated by methoxyamine,
suggesting the importance of Schiff base formation between peptide amino groups and the lipid aldehyde
function. PoxnoPC and similar aldehyde bearing oxidatively modiﬁed phospholipids could represent novel
molecular targets for AMPs.
© 2008 Elsevier B.V. All rights reserved.IntroductionInnate immune system of multicellular organisms relies as a ﬁrst
line of defense against opportunistic infections on inducible gene-
encoded host-defense peptides [1–3], referred to as antimicrobial
peptides. To date, hundreds of AMPs from various sources have been
identiﬁed or synthesized de novo [4,5]. While they exhibit substantial
diversity in their sequences, two recurrent structural characteristics
are evident, viz. a net positive charge and amphipathicity owing to
both hydrophobic and hydrophilic patches on their molecular surfaces
[6]. These features promote the interactions of AMPswith pronounced
selectivity towards membranes enriched in negatively charged
phospholipids and lipopolysaccharides present in bacteria. Several
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l rights reserved.the binding of AMPs have been forwarded [7–9], each resulting in
permeabilization and depolarization of the target cell or organism
membrane. There is, however, evidence indicating that for certain
AMPs membrane interactions in vivo are accompanied by antimicro-
bial activity due to association to intracellular targets or immunomo-
dulation via stimulation in vertebrates of their adaptive immune
response [10,11].
We have investigated the membrane association of several AMPs,
including temporins B and L, indolicidin, and the F27W mutant of LL-
37 [12–14]. Temporins were found in the skin of the European red frog
Rana temporaria [15] and constitute a family of some of shortest (10–
13 residues) linear AMPs known with a net positive charge and an
amidated C-terminus. Temporin B (LLPIVGNLLKSLL–NH2, charge=+2)
and temporin L (FVQWFSKFLGRIL–NH2, charge=+3), assume an
amphipathic α-helical conformation in apolar solvent [14] and have
been suggested to permeabilize target membranes by the barrel-stave
mechanism [15]. They also form similarly to several other AMPs Congo
red staining amyloid-type ﬁbrils in the presence of acidic phospho-
lipids [8,9].
Indolicidin is secreted by human macrophages and is a linear
peptide consisting of 13 amino acids, amidated at the C-terminus and
with an unusual amino acid composition with ﬁve Trp and three Pro
residues, ILPWKWPWWPWRR–NH2 (charge=+4). It does not adopt
any classical secondary structure and does not display the character-
istic amphiphatic nature of antimicrobial peptides [16]. Indolicidin
adopts an extended conformation, with a wedge-type shape and with
its Trp residues in a trough, ﬂanked by the positively charged regions
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with the hydrophobic core making contacts in the interfacial regions
while the ﬂanking parts would interact more prominently with the
lipid headgroups. Indolicidin has been suggested to insert into the
hydrophobic core of the membrane and form channel aggregates [16].
The 4.5 kDa cationic amphipathic peptide LL-37 (LLGDFFRKSKEKIG-
KEFKRIVQRIKDFLRNLVPRTES) is found in humans and belongs to the
class of α-helical AMPs. At physiological pH it contains 11 positiveFig. 1. Penetration of antimicrobial peptides into lipid monolayers residing on low ionic str
pressure (Δπ) following the addition of 0.3 μM temporin B (A), temporin L (B), indolicidin (C
Monolayer compositions were DMPC (○), DMPC:DMPG=8:2 (□), DMPC:PoxnoPC=8.2 (▼),charges (due to 6 Lys and 5Arg) and 5negative charges (due to 3Glu and
2 Asp)with a resulting net charge of +6. Expressed throughout the body,
LL-37 has, in addition to its direct antimicrobial activity, been shown to
be involved in reproduction [17], differentiation [18], andmodulation of
the innate immune system [19]. It has been shown to associate on the
surface of the bilayer in the form of stable α-helices and subsequently
permeate the membrane by a carpet-like mechanism [20,21]. In the
present study we utilized a F27W mutant of LL-37 so as to allow theength buffer (20 mM Hepes, 0.1 mM EDTA, pH 7.0), illustrated as increment in surface
), or LL-37(F27W) (D) into the subphase as a function of the initial surface pressure π0.
and DMPC:PazePC=8:2 (▲).
Table 1
Monolayer critical packing pressures (πc) and estimated increase of surface pressure
from initial value of 10 mN/m following peptide addition (Δπmax) for temporins B and L,
indolicidin, and LL-37(F27W)
Lipid composition πc (mN/m) Δπmax (at 10 mN/m)
No salt 150 mM NaCl No salt 150 mM NaCl
Temporin B DMPC 37.7 36.3 16.1 17.7
XDMPG=0.2 48.0 40.5 21.0 18.1
XPoxnoPC=0.2 45.8 50.6 20.0 20.4
XPazePC=0.2 37.7 38.5 18.5 17.9
Temporin L DMPC 47.1 45.2 15.8 15.9
XDMPG=0.2 51.9 45.9 18.9 18.9
XPoxnoPC=0.2 46.7 49.2 19.9 20.6
XPazePC=0.2 45.1 44.2 16.3 17.5
Indolicidin DMPC 47.2 32.3 5.2 12.3
XDMPG=0.2 60.1 49.2 11.7 5.8
XPoxnoPC=0.2 47.0 44.1 12.9 12.2
XPazePC=0.2 40.9 42.4 11.7 8.0
LL-37(F27W) DMPC 38.8 39.0 18.5 21.7
XDMPG=0.2 50.0 45.6 25.5 23.6
XPoxnoPC=0.2 42.2 39.7 24.0 26.2
XPazePC=0.2 41.5 36.9 21.4 23.6
Data were taken from Figs. 1 and 2.
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spectroscopy [12]. Importantly, this mutant has been demonstrated to
retain essentially identical antimicrobial activity as wild type LL-37 (as
veriﬁed for Bacillus subtilis and Staphylococcus aureus). This mutant
further adopts similar α-helical secondary structure upon binding to
liposomes and intercalates into phospholipid monolayers equally well
as the wild type LL-37, as determined by circular dichroism and
monolayer penetration measurements, respectively [12].
Irrespectiveof their exactmodeof action, discriminationbetween the
membranes of the target and host organisms represents a pivotal issue
regarding AMP function on molecular level. To this end, the lack acidic
phospholipids from the outer leaﬂet of eukaryotic plasma membranes
might provide a general mechanism of host cell recognition [22]. This
notion is supported by a wealth of experimental evidence from studies
withmodel phospholipidmembranes, suchasmonolayers [23] and large
or giant unilamellar vesicles [14]. Yet, cellularmembranes undergo upon
infection and inﬂammation a drastic modiﬁcation due to lipid oxidation
resulting in the formation of a myriad of phospholipids with modiﬁed
acyl chains containing various functional groups [24]. Importantly, also
the membranes of invading bacteria are exposed to reactive oxygen
species (ROS) secreted by activated leukocytes at sites of infection. In the
present study we demonstrate that the inclusion of aldehyde group
bearing oxidatively modiﬁed phospholipid PoxnoPC into zwitterionic
DMPC matrix in Langmuir monolayers or large unilamellar vesicles
results in augmented membrane association of four AMPs, temporins B
and L, indolicidin, and F27W mutant of LL-37, rivaling that observed in
the presence of an equal mole fraction of the negatively charged PG.
Notably, in physiological saline the efﬁciency of PG in promoting
membrane interactions of the above peptideswas considerably reduced,
whereas the effect due to PoxnoPC remained essentially unaffected. In
contrast, another phospholipid oxidation product, PazePC bearing a
carboxylic function was found to possess negligible ability to promote
membrane association of AMPs. The above data suggest a functional role
of oxidized phospholipids in serving as molecular targets for AMPs,
possibly relating in addition to their membrane perturbing properties to
their capability to modulate both innate and adaptive immunity via
different mechanisms including induction of cytokine production,
stimulation of leukocyte chemotaxis, and promotion of monocyte-
derived dendritic cell maturation [10].
Materials and methods
Materials
1-Palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine (PazePC), 1-palmitoyl-2-(9′-
oxo-nonanoyl)-sn-glycero-3-phosphocholine (PoxnoPC), 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC), and 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]
(DMPG, Na+-salt) were from Avanti Polar Lipids (Alabaster, AL). NaCl, Hepes, EDTA, and
methoxyamine hydrochloride were from Sigma (St. Louis, MO). Indolicidin was from
Bachem (Bubendorf, Switzerland), temporin B from Synpep (Dublin, CA), and temporin L
and LL-37(F27W) from Caslo (Lyngby, Denmark). The purity of the peptides was N95% for
indolicidin, temporin B, and LL-37, and N97% for temporin L as veriﬁed by high
performance liquid chromatography analyses provided by their respective suppliers. The
purity of the lipidswas checked by thin-layer chromatography on silicic acid-coated plates
(Merck,Darmstadt, Germany)using chloroform/methanol/water/ammonia (65:20:2:2, v/v)
as the eluent. Examination of the plates after iodine staining revealed no impurities.
Concentrations of the phospholipid stock solutions were determined gravimetrically with
a high precision electrobalance (Cahn Instruments, Cerritos, CA).
Penetration of the peptides into lipid monolayers
Appropriate amounts of lipid stock solutions were mixed in chloroform to obtain
the desired compositions, whichwere subsequently spread onto air/buffer interface in a
magnetically stirred circular Teﬂon wells with a subphase volume of 1.2 ml (Multiwell
plate, Kibron Inc., Espoo, Finland). Surface pressure (π) was monitored with a Wilhelmy
wire attached to a computer-controlled Langmuir type ﬁlm balance (μTroughX, Kibron)
using the embedded features of the control software (FilmWare 3.57, Kibron),
essentially as described previously [25]. After stabilization of the applied monolayer
to an initial value of surface pressure π0 the peptides were injected into the subphase
(0.3 μM ﬁnal concentration) where after the increment in π (Δπ) due to their
intercalation into the ﬁlm was followed. The data are represented as Δπ vs π0, yielding
upon least-squares linear ﬁtting straight lines with negative slopes, the x-axis interceptof which represent the critical packing pressure πc, i.e. the maximum value of initial
pressure at which the peptides intercalate into the monolayer [26,27]. All measure-
ments were performed at ambient temperature of ~23 °C.
Preparation of large unilamellar vesicles (LUVs)
Appropriate amounts of lipid stock solutions were mixed in chloroform to obtain
the desired compositions. The solvent was removed under a stream of nitrogen and the
lipid residuewas subsequentlymaintained overnight under a reduced pressure. The dry
lipid ﬁlm was hydrated at 50 °C in 20 mM Hepes, 0.1 mM EDTA, pH 7.0 or the same
buffer containing 150 mM NaCl, to yield a lipid concentration of 2 mM. The resulting
dispersions were extruded through a 100 nm pore size polycarbonate ﬁlter (Millipore
Corp., Bedford, MA) using a Liposofast low pressure homogenizer thermostated at 50 °C
with a circulating water bath (Avestin, Ottawa, Canada) to obtain large unilamellar
vesicles with average diameter of ~80–100 nm as determined by dynamic light
scattering [28,29].
Fluorescence spectroscopy
Peptides were added to a suspension of LUVs (total lipid concentration of 400 μM) in
indicated buffer maintained at 25 °Cwith continuous stirring in a 1 cm path length quartz
cuvette yielding a ﬁnal concentration of 4 μM in a total volume of 2 ml (peptide/lipid ratio
of 1:100). After 1 h of equilibration, ﬂuorescence emission spectra were recorded with
Perkin-Elmer LS 50B ﬂuorescence spectrometer with both emission and excitation band
passes set at 5 nm and using excitationwavelength of 280 nm. The obtained spectra were
corrected for the contribution of light scattering in the presence of vesicles.
Quenching of Trp emission by acrylamide
In order to reduce absorbance by acrylamide, excitation of Trp at 295 nm instead of
280 nm was used [30]. Proper aliquots of 3 M acrylamide solution were added to the
peptide in the presence or absence of liposomes at a peptide/lipid molar ratio of 1:100.
The ﬂuorescence intensity values obtained were corrected for dilution, and the scatter
contribution was derived from acrylamide titration of a vesicle blank. The data were
analyzed in terms of the Stern–Volmer equation [31],
F0
F
= 1 + KSV Q½  ð1Þ
where F0 and F represent the ﬂuorescence intensities in the absence and the presence of
the quencher Q, respectively, and KSV is the Stern–Volmer quenching constant, which is
a measure of the quenching efﬁciency and proportional to the accessibility of Trp to
acrylamide. On the premise that acrylamide does not signiﬁcantly partition into the
bilayer [30], the value for KSV can be considered to be a reliable reﬂection of the
bimolecular rate constant for the collisional quenching of the Trp residues present in the
aqueous phase. Accordingly, KSV is determined by the amount of non-vesicle-associated
free peptide, as well as the fraction of the peptide residing on the surface of the bilayer.
Results
In order to pursue the interactions of AMPs with membranes
containing oxidized phospholipids we ﬁrstmeasured the penetration of
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More speciﬁcally, the insertion of these AMPs into monolayers with
different initial surface pressures π0 was observed by recording the
increase in the surfacepressureΔπ following theaddition of thepeptides
into the subphase. Importantly, in order to avoid possible inﬂuence of
different phospholipid phaseswe used, in addition to the two secondary
products of lipid peroxidation PoxnoPC or PazePC (at X=0.2), DMPC and
DMPG (X=0.2), which under the conditions employed form liquidFig. 2. Penetration of antimicrobial peptides into lipid monolayers residing on buffer with 150
temporin B (A), temporin L (B), indolicidin (C), or LL-37(F27W) (D) into the subphase as a fun
DMPG=8:2 (□), DMPC:PoxnoPC=8.2 (▼), and DMPC:PazePC=8:2 (▲).expanded (“ﬂuid”) ﬁlms [32], similarly to the unsaturated lipids such as
POPC and POPG commonly found in biomembranes. Further, as no
signiﬁcance for structural features other than the acidic headgroup have
been found for the interaction of AMPs with liquid expanded
membranes, the above saturated lipids can be concluded to be
representative also for unsaturated phospholipids, e.g. POPC and POPG.
In a low ionic strength subphase both temporins B and L were
highly membrane active producing signiﬁcant increment in surfacemMNaCl, shown as increment in surface pressure (Δπ) following the addition of 0.3 μM
ction of the initial surface pressure π0. Monolayer compositions were DMPC (○), DMPC:
Fig. 3. Tryptophan ﬂuorescence spectra of temporin L (A), indolicidin (B), and LL-37(F27W) (C) in low ionic strength buffer or in buffer with 150mMNaCl () (D, E, and F, respectively)
and in the presence of liposomes composed of DMPC (○), DMPC:DMPG=8:2 (□), DMPC:PoxnoPC=8:2 (▼), and DMPC:PazePC=8:2 (▲).
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Table 2
Maximum emission wavelengths of Trp ﬂuorescence of temporin L, indolicidin, and LL-
37(F27W) (λmax) and its blueshift compared to value recorded in aquous buffer (Δλmax)
induced by liposomes of indicated compositions
LUV composition λmax (nm) Δλmax (nm) RFI
No
salt
150 mM
NaCl
No
salt
150 mM
NaCl
No
salt
150 mM
NaCl
Temporin L – 352 352 – – 166 161
DMPC 338 337 14 15 214 222
XDMPG=0.2 328 332 24 20 263 245
XPoxnoPC=0.2 334 335 18 17 99 91
XPazePC=0.2 337 338 15 14 155 168
Indolicidin – 352 352 – – 475 473
DMPC 341 341 11 11 802 922
XDMPG=0.2 340 340 12 12 960 953
XPoxnoPC=0.2 342 342 10 10 456 420
XPazePC=0.2 341 342 11 10 791 607
LL-37(F27W) – 352 352 – – 197 210
DMPC 337 336 15 16 201 189
XDMPG=0.2 337 336 15 16 201 197
XPoxnoPC=0.2 338 337 14 15 142 118
XPazePC=0.2 337 336 15 16 211 192
Data were taken from Figs. 3 and 4.
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Also indolicidin intercalated into the monolayers, albeit somewhat
less effectively (Fig. 1C), whereas LL-37(F27W) displayed membrane
activity comparable to the temporins. As expected from their positive
net charges (+2, +3, +4, and +6 for temporin B, temporin L, indolicidin,
and LL-37(F27W), respectively) all four peptides used in the present
study interact preferably with monolayers containing acidic phos-
pholipids [13,23]. In keeping with previous studies, highest values of
πc were recorded for ﬁlms with XDMPG=0.20. However, while PazePC
contains an ionizable carboxylic function in its sn-2 acyl with a net
negative charge, only indolicidin displayed augmented penetration
into monolayers containing this oxidatively modiﬁed phospholipid
(X=0.20) below surface pressure of ~35 mN/m.
Interestingly and unexpectedly, the intercalation of all peptides
into monolayers containing the aldehyde group bearing PoxnoPC was
considerably enhanced over neat DMPC, this oxidatively modiﬁed
phospholipid being almost as effective as DMPG in promoting peptide
penetration. With DMPG and PoxnoPC (X=0.20) the value of πc for
temporin B increased from ≈38 mN/m measured for neat DMPC up to
≈48 and ≈46 mN/m, respectively (Table 1). For temporin L there was
less variation in πc between different monolayer compositions, with
DMPG (X=0.20) yielding the highest value of ≈52mN/m. In the case of
indolicidin and LL-37(F27W), incorporation of DMPG into the
monolayer resulted in clearly higher values for πc (≈60 and ≈50 mN/
m, respectively) compared to other lipid compositions. Notably, for all
four peptides both DMPG and PoxnoPC enhanced considerably the
intercalation at low surface pressures as evidenced by values of Δπ at
π0=10 mN/m (Table 1).
The above experiments were conducted in a low ionic strength
medium. Accordingly, it was of interest to study the monolayer
penetration using a subphase with physiological saline. Intriguingly,
the two temporins and indolicidin intercalated into PoxnoPC contain-
ing monolayers as efﬁciently as from a low ionic strength subphase,
and only a minor decrement in πc was noted for LL-37(F27W). Instead,
as expected, their penetration into DMPG containing monolayers
decreased due to screening of the electrostatic interactions by salt
(Fig. 2). More speciﬁcally, in 150 mM NaCl temporin B inserted into
neat DMPC monolayers up to π0≈36 mN/m, while its penetration was
lightly augmented by both PazePC and DMPG (X=0.20) with the value
for πc increasing up to ≈38 and ≈40 mN/m, respectively. Notably, the
intercalation of temporin B into a monolayer containing PoxnoPC was
enhanced with πc increasing up to ≈51 mN/m, a value signiﬁcantly
higher than measured in a low ionic strength medium (≈46 mN/m,
Table 1).
In contrast to temporin B, with 150 mM NaCl in the subphase the
presence of PazePC or DMPG (X=0.20) into the monolayers enhanced
the penetration of temporin L only at low surface pressures (≈10–
15 mN/m), while the πc values for these monolayers remained nearly
identical (≈45mN/m). Similarly to temporin B, PoxnoPC promoted the
monolayer penetration of temporin L yielding πc≈49 mN/m. In
physiological NaCl the membrane intercalation of indolicidin into
neat DMPC monolayers was considerably reduced, with πc decreasing
from 47 to 32 mN/m. However, concomitantly the penetration at
lower surface pressures was promoted, exceeding that observed in the
presence of DMPG. Also for monolayers containing PazePC the
magnitude of penetration was reduced, albeit less than for DMPG.
Similarly to temporins B and L, the most effective intercalation of
indolicidin was found into monolayers containing PoxnoPC. With the
exception of neat DMPC, the introduction of 150 mM NaCl into the
subphase led to diminished intercalation of LL-37(F27W) into
phospholipidmonolayers. Again, highest reduction in πc was observed
for monolayers containing DMPG (X=0.20). The penetration of LL-37
(F27W) into PoxnoPC containing monolayers was slightly attenuated
in the presence of physiological saline. However, as seen for
indolicidin, the penetration at lower surface pressure was promoted
exceeding that observed for DMPG.In order to obtain further insight into the interaction of AMPs with
these two oxPLs we used the intrinsic Trp ﬂuorescence of temporin L,
indolicidin, and LL-37(F27W). To allow the comparisonwith the above
monolayer data the same phospholipids were used and temperature
maintained at 25 °C, where the LUVs are above their main transition
and in liquid disordered (“ﬂuid”) state. Emission spectra of these three
peptides were recorded in the absence as well as in the presence of
LUVs of different lipid compositions (viz. DMPC as such and with
DMPG, PoxnoPC, and PazePC, each at X=0.20) both in buffer only and
in 150mMNaCl. In aqueous solution the Trp residue(s) of the peptides
emit with a maximum at ~352–354 nm, indicating them to reside in a
polar environment [33,34]. A relocation of Trp residues into a less
polar environment such as the hydrocarbon phase of lipid membranes
causes changes in Trp ﬂuorescence intensity and emission maximum
[30,35]. Representative ﬂuorescence spectra of temporin L (Fig. 3) in
low ionic strength reveal, upon the addition of DMPC LUVs, a blue shift
in λmax by 14 nm (Table 2), together with an increase in the emission
intensity, both indicative of association of the peptide with the
vesicles. More pronounced increase in both intensity and blue shift
(24 nm) were observed following the addition of vesicles containing
DMPG, in keeping with previous studies [14]. For LUVs containing
PazePC (XPazePC=0.2), the blue shift was smaller (15 nm) compared to
XDMPG=0.2 while the emission intensity was attenuated compared to
neat DMPC vesicles. Similar blue shift by 18 nm together with
augmented decrement in tryptophan emission was observed also for
PoxnoPC (XPoxnoPC=0.2, Fig. 2 and Table 2). In physiological saline the
emission intensity after the addition of DMPG containing vesicles
decreased, in contrast to increase for PazePC and DMPC. Interestingly,
the impact of PoxnoPC was identical irrespective of the increase in
ionic strength (Fig. 4).
The blue shift for indolicidin was almost completely insensitive to
vesicle lipid composition and ionic strength (Figs. 3 and 4). Instead,
considerable variation in emission intensity was observed. Both with
and without 150 mM NaCl the addition of DMPG containing vesicles
resulted in the highest tryptophan emission. The ﬂuorescence
intensity in the presence of vesicles containing XPazePC=0.2 equaled
that measured for neat DMPC LUVs under low ionic strength. In the
presence of LUVs with XPoxnoPC=0.2, as well as XPazePC=0.2 and in
physiological saline, Trp emission intensity was lower than for neat
DMPC vesicles (Table 2). With the exception of a marked decrease
with PoxnoPC containing vesicles, essentially no changes in ﬂuores-
cence quantum yield were observed following the binding of LL-37
(F27W) to liposomes. As for indolicidin, the blue shift of emission
Fig. 4. Stern–Volmer plots for acrylamide quenching of ﬂuorescence of the Trp residues of temporin L (A), indolicidin (B), and LL-37(F27W) (C) in low ionic strength buffer or in buffer
with 150 mM NaCl () (C, E, and F, respectively) and in the presence of liposomes composed of DMPC (○), DMPC:DMPG=8:2 (□), DMPC:PoxnoPC=8:2 (▼), and DMPC:PazePC=8:2 (▲).
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Table 3
The Stern–Volmer quenching constants KSV (M−1) of acrylamide for temporin L,
indolicidin, and LL-37(F27W) in the absence and the presence of vesicles of the
indicated compositions
KSV (M−1)
LUV composition No salt 150 mM NaCl
Temporin L – 12.93±0.16 12.90±0.11
DMPC 1.48±0.08 1.65±0.07
XDMPG=0.2 1.01±0.06 1.22±0.05
XPoxnoPC=0.2 0.88±0.14 1.22±0.11
XPazePC=0.2 2.18±0.09 2.34±0.05
Indolicidin – 9.31±0.15 9.29±0.10
DMPC 2.37±0.04 2.30±0.06
XDMPG=0.2 1.25±0.01 1.37±0.02
XPoxnoPC=0.2 1.91±0.03 2.04±0.03
XPazePC=0.2 2.62±0.03 2.63±0.02
LL-37(F27W) – 11.87±0.23 11.45±0.14
DMPC 2.40±0.07 2.59±0.09
XDMPG=0.2 1.31±0.07 1.64±0.05
XPoxnoPC=0.2 1.58±0.07 1.82±0.07
XPazePC=0.2 1.83±0.06 2.24±0.07
Fig. 5. Penetration of temporin L into lipid monolayers residing on 20 mM Hepes,
0.1 mM EDTA, 150 mM NaCl, pH 7.0 and in the absence (open symbols) or in the
presence (closed symbols) of 1 mM methoxyamine, depicted as the increment in
surface pressure (Δπ) following the addition of 0.3 μM temporin L into the subphase as a
function of the initial surface pressure π0. Monolayer compositions were DMPC (○),
DMPC:DMPG=8:2 (□, ■), DMPC:PoxnoPC=8:2 (▽, ▼).
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composition.
In order to verify the insertion of these three peptides into the
hydrophobic region of the bilayers, indicated by the above changes in
the Trp emission spectra, quenching by acrylamide was used [31].
Importantly, this quencher is devoid of electrostatic interactions with
the headgroups of negatively charged lipids [33] and because of being
highly water soluble it provides a measure of the solvent exposure of
the Trp residues of the peptides. Stern–Volmer plots of the Trp
quenching by acrylamide recorded in the absence and in the presence
of vesicles of indicated lipid compositions reveal in all cases a
concentration-dependent decrease in ﬂuorescence (Figs. 3 and 4).
However, decrease in ﬂuorescence is signiﬁcantly reduced in the
presence of liposomes, demonstrating reduced accessibility of Trp to
the quencher, and thus insertion of the peptides into the vesicles.
At low ionic strength the values of KSV for temporin L show amajor
decrease with neat DMPC vesicles while slightly better access of
acrylamide to Trp is seen for LUVs with XPazePC=0.20. Instead,
compared to DMPC the values for KSV were further decreased in the
presence of DMPG and PoxnoPC containing LUVs. Similar changes in
KSV values were evident also for indolicidin and LL-37(F27W)
following incubation with liposomes, with the exception of the
binding of the latter peptide to PazePC containing vesicles resulting in
less efﬁcient quenching compared to neat DMPC LUVs (Table 3). At
150 mM NaCl a general increase in quenching efﬁciency of Trp
ﬂuorescence was observed for all three peptides indicating decreased
membrane partitioning and/or relocation of the Trp residue(s) closer
to the interface following increase in ionic strength. Again, however,
lowest KSV values were measured for liposomes containing DMPG or
PoxnoPC (Table 3).
Discussion
AMPs bind avidly to membranes containing acidic phospholipids
and, accordingly, their primary targets have been concluded to be the
negatively charged lipids, abundant in the outer surface of bacteria
[36–38]. Our ﬁndings reported here provide further evidence for their
mechanisms of action on cells being more complex. Accordingly, our
monolayer data demonstrate at physiological ionic strength efﬁcient
intercalation of four AMPs into PoxnoPC containing ﬁlms, up to the
critical packing density yielding values for πc of 40 (LL-37), 45
(indolicidin) and 50 mN/m (temp L, temp B), thus exceeding the
equilibrium lateral pressure of ~33 mN/m estimated for biomem-
branes [39]. Furthermore, the magnitude of surface pressure increase
Δπ clearly exceeds for all these peptides the effect observed using theacidic phospholipid, DMPG (Table 1). It was also of interest that
binding to the negatively charged oxidized lipid PazePC was
signiﬁcantly weaker than to the zwitterionic PoxnoPC, approaching
the insertion of temporins B and L into DMPC.
The above somewhat unprecedented interaction could be con-
ﬁrmed using Trp ﬂuorescence to monitor the binding of temporin L,
indolicidin and LL-37(F27W) to liposomes containing PoxnoPC.
PoxnoPC is zwitterionic with no net charge. Accordingly, one of the
factors promoting its association with AMPs could be efﬁcient
hydrogen bonding to the aldehyde moiety. The latter resides in a
highly anisotropic membrane environment and at XPoxnoPC=0.2 its
local content is high. In addition, being contained in a hydrocarbon
chain and thus accommodated in a low dielectric milieu the strength
of H-bonds formed should be enhanced [40]. Another and more likely
possibility is Schiff base formation between the aldehyde group and
the primary amines of the peptides, as demonstrated for PoxnoPC and
apolipoprotein AI [41]. To asses this we performed monolayer
experiments with 1 mM methoxyamine in the subphase (with
150 mM NaCl) as an aldehyde scavenger [42], prior to the injection
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the four peptides studied. Accordingly, an inhibitory effect should for
this peptide override also the nonspeciﬁc hydrophobicity driven
membrane partitioning. Importantly, the intercalation of temporin L
into monolayers containing acidic phospholipid DMPG is unaffected by
methoxyamine (Fig. 5). In contrast, for PoxnoPC containing monolayers
markedly decreased intercalation of temporin L was observed. Similar
results were obtained in a low ionic strengthmedium (data not shown).
Hence, the Schiff base adduct formation between the amino groups of
the peptides and the aldehyde function is likely to be involved in the
PoxnoPC–peptide interaction, as reported previously for other phos-
pholipid aldehydes [43,44]. Finally, irrespective of the exact molecular
level mechanisms involved the cooperative nature of processes in
phospholipid membranes can be further anticipated to promote
efﬁcient association of AMPs with PoxnoPC.
Trp ﬂuorescence data show that this residue of temporin L becomes
in a PoxnoPC containing bilayer accommodated in a hydrophobic
milieu, with a 18 nm blue shift in λmax. For comparison the values for
Δλmax in DMPG (X=0.20) and neat DMPC are 24 and 14 nm, respectively
(Table 2). Yet, the quantum yield for W4 of temporin L in PoxnoPC is
reduced, being ~56% of the value recorded in buffer with 150 mMNaCl
in the absence of liposomes. The lower quantumyield could result from
H-bonding to the vicinity of W4 or, alternatively, the existence of two
populations ofW4, one in a hydrophobic milieu and another with a low
quantum yield polar environment. The latter mechanism is unlikely. As
Trp of the temporin L is poorly accessible to thewater soluble quencher,
acrylamide, it is feasible that this residue resides within the membrane,
most likely in an environment also containing the aldehyde moiety of
PoxnoPC. To this end, equal KSV values (1.22) were measured for W4
with PoxnoPC and DMPG containing bilayers, revealing limited access
of the water soluble quencher acrylamide to this residue. Quantitatively
similar datawere obtained by ﬂuorescence spectroscopy for indolicidin.
Yet, because of its ﬁve Trps and non-helical conformation the discussion
of its topology when bound to PoxnoPC containing membrane on the
basis of these data alone would be ambiguous. Yet, efﬁcient intercala-
tion of indolicidin into PoxnoPC containing monolayers, particularly at
higher packing densities is certainly unexpected and is likely to result
from cooperative hydrogen bonding of this peptide to the aldehyde
group of the PoxnoPC, similarly to temporins B and L.
The Trp ﬂuorescence data for LL-37(F27W) reveal that upon
association with phospholipid bilayers also Trp of this peptide resides
in a hydrophobic milieu, with a blue shift in emission maximum of
~15 nm measured for all lipid compositions (Table 2). However, in
contrast to the three other peptides only minor changes in ﬂuorescence
quantum yield are seen between peptide free in solution and bound to
neat DMPC and DMPG or PazePC containing LUVs. A plausible
explanation to this is quenching arising from peptide conformational
changes upon membrane association bringing the single Trp in closer
proximity to one of the charged residues of LL-37 (F27W). Similarly to
temporin L and indolicidin decrease in emission intensity in the
presence of PoxnoPC containing LUVs was evident for LL-37 (F27W),
attributable to direct quenching of Trp by the aldehyde moiety or
alternatively self-quenching caused by PoxnoPC promoted aggregation
of LL-37(F27W) monomers.
Our results raise several interesting issues. First of all, it is obvious
that interactions of peptides and proteins with speciﬁc oxPL structures
should be studied in detail, in particular as elevated levels of these lipids
are found in pathological conditions such as infection, inﬂammation,
and cancer [45–47]. Phosphatidylcholines bearing a cis-9 double bond
represent a major fraction in all biomembranes and yield PoxnoPC and
PazePC upon peroxidation. Accordingly, while no quantitative data are
available on the amounts of these oxPLs in biomembrane following ROS
attack, it seems likely that their contents in membranes are signiﬁcant.
These oxPLs are also found in oxidized low-density lipoprotein (oxLDL),
and are suggested to be involved in the development of atherosclerosis
[48–50]. Koppaka and Axelsen have demonstrated the paradigm foramyloid-forming peptides, Aβ, to associate with oxidatively damaged
PCs [51,52]. Our own preliminary results also show the human islet
amyloid polypeptide, IAPP to bind to oxidized PCs (Domanov, Y. A.,
Mattila, J.-P., Varis, T., Sabatini, K., and Kinnunen, P. K. J., unpublished
data). It is tempting to speculate that secondary products of phospho-
lipid oxidation may represent novel molecular targets mediating the
cytotoxic effects of peptides and proteins forming amyloid-type ﬁbrils.
The possible contribution of ROS to bacterial killing has remained
unclear. Neutrophils represent an essential component in resolution
of acute microbial infections. Following phagocytosis of bacteria,
neutrophil granules containing among others antimicrobial proteins
and peptides such as lysozyme and defensins, fuse with the formed
phagosome exposing the engulfed bacteria to their content. Con-
comitantly O2− generated by NADPH oxidase residing in the phagoso-
mal membrane is converted into hydrogen peroxide by superoxide
dismutase inside the phagosome [53]. It has been suggested that O2−
generation is required to release and activate certain cationic
proteases inside the phagosome [54]. In the light of the present
results it seems possible that ROS and the action of AMPs could be
interrelated, with ROS induced lipid oxidation in phagolysosome
generating high afﬁnity AMP binding sites on the bacterial membrane.
Studies exploring these issues are currently in progress in our
laboratory.
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